Global X Genomics & Biotechnology ETF (GNOM)
Global X
- Page updated:
- Sep 7, 2026
- Data as of:
- Sep 3, 2026
Fund identity
- Ticker
- GNOM
- Fund name
- Global X Genomics & Biotechnology ETF
- Fund type
- ETF
- Listing venue
- NASDAQ
- Currency
- USD
- Domicile
- US
- Inception
- Apr 5, 2019
Structure and strategy
- Sponsor
- Global X
- Management approach
- Passive
- Strategy
- Seeks investment results corresponding generally, before fees and expenses, to the Solactive Genomics Index.
- Portfolio scope
- Genomics-related equities spanning gene editing, sequencing, genetic medicine and computational genomics
- Portfolio implementation
- Thematic index tracking
- Benchmark
- Solactive Genomics Index
- Benchmark symbol
- SOLGNOM
- Asset class
- Equity
- Category
- Genomics
The theme describes index eligibility/exposure.
Costs and minimums
- Gross expense ratio
- 0.50%
- Total expense ratio
- 0.50%
- Ongoing fee as of
- Sep 7, 2026
Size and distributions
- Assets under management
- $92.57M
- Assets under management scope
- Fund
- Reported holdings count
- 50
- Distribution frequency
- Semi-Annually
Sources
- Global X Genomics & Biotechnology ETF — issuer product page — Global X · data as of Sep 7, 2026
Learn the basics
ROIStreet publishes this reference data for education and research. Figures are as of the dates shown, are not real-time quotes, and are not investment advice. Verify details with the issuer or provider before acting.